Search

Sort by:
Results 471 - 480 of 902 for Abbreviate
  • Barr Pharmaceuticals confirms Eloxatin injectable patent challenge
    News - 10 Jan 2008
    Barr Pharmaceuticals, Inc. has announced that its subsidiary, Barr Laboratories, has initiated a challenge of the patents listed by Sanofi-Aventis U.S. LLC in connection with its Eloxatin(R)...
  • Mylan announces FDA approval for Cetirizine Hydrochloride tablets
    News - 2 Jan 2008
    Mylan Inc. has announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Cetirizine...
  • Barr confirms patent challenge of Ritalin LA
    News - 5 Nov 2007
    Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Novartis Pharmaceuticals Corporation in connection with its...
  • Mylan settles Levetiracetam patent case
    News - 4 Oct 2007
    Mylan Inc. has announced that it and its subsidiary Mylan Pharmaceuticals Inc. have entered into an agreement to settle pending litigation with UCB Societe Anonyme and UCB Pharma Inc. (collectively,...
  • Barr confirms UROXATRAL patent challenge
    News - 25 Sep 2007
    Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sanofi- Aventis U.S. LLC in connection with its UROXATRAL...
  • Watson Pharmaceuticals receives FDA approval for generic Duragesic
    News - 21 Aug 2007
    Watson Pharmaceuticals, Inc. announced today that it has received final approval from the United States (U.S.) Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for...
  • Mylan receives FDA approval for Verapamil Hydrochloride capsules
    News - 13 Aug 2007
    Mylan Laboratories Inc. has announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for...
  • Court rules in favor of Sandoz on Toprol Xl patent
    News - 26 Jul 2007
    Sandoz was pleased to learn this week that the U.S. Court of Appeals in St. Louis has affirmed a summary judgment by U.S. District Judge Rodney Sippel invalidating patent protection on Toprol XL(R), a...
  • Lupin receives approval for Amlodipine tablets
    News - 18 Jul 2007
    Lupin Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Amlodipine Besylate...
  • Barr confirms Xopenex patent challenge
    News - 17 Jul 2007
    Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sepracor Inc. in connection with its Xopenex (Levalbuterol...

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback